Olaparib significantly delays photoreceptor loss in a model for hereditary retinal degeneration
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The enzyme poly-ADP-ribose-polymerase (PARP) mediates DNA-repair and rearrangements of the nuclear chromatin. Generally, PARP activity is thought to promote cell survival and in recent years a number of PARP inhibitors have been clinically developed for cancer treatment. Paradoxically, PARP activity is also connected to many diseases including the untreatable blinding disease Retinitis Pigmentosa (RP), where PARP activity appears to drive the pathogenesis of photoreceptor loss. We tested the efficacy of three different PARP inhibitors to prevent photoreceptor loss in the rd1 mouse model for RP. In retinal explant cultures in vitro, olaparib had strong and long-lasting photoreceptor neuroprotective capacities. We demonstrated target engagement by showing that olaparib reduced photoreceptor accumulation of poly-ADP-ribosylated proteins. Remarkably, olaparib also reduced accumulation of cyclic-guanosine-monophosphate (cGMP), a characteristic marker for photoreceptor degeneration. Moreover, intravitreal injection of olaparib in rd1 animals diminished PARP activity and increased photoreceptor survival, confirming in vivo neuroprotection. This study affirms the role of PARP in inherited retinal degeneration and for the first time shows that a clinically approved PARP inhibitor can prevent photoreceptor degeneration in an RP model. The wealth of human clinical data available for olaparib highlights its strong potential for a rapid clinical translation into a novel RP treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, intravitreal injection of the PARP inhibitor, olaparib, has shown promising neuroprotective effect in mouse models of IRDs (Sahaboglu et al., 2016).”
From Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy (2025) · cites this paper as Sahaboglu et al., 2016
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain
Kriaucionis, S., & Heintz, N. (2009) · Science · doi:10.1126/science.1169786 · Cited by 2,700
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Murai, J., Huang, S.-Y. N., Das, B. B., Renaud, A., Zhang, Y., Doroshow, J. H., Ji, J., Takeda, S., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2753 · Cited by 2,192
The Major Cell Populations of the Mouse Retina
Jeon, C.-J., Strettoi, E., & Masland, R. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08936.1998 · Cited by 1,429
Bowes, C., Li, T., Danciger, M., Baxter, L. C., Applebury, M. L., & Farber, D. B. (1990) · Nature · doi:10.1038/347677a0 · Cited by 852
Poly(ADP-Ribose) in the Cellular Response to DNA Damage
Berger, N. A. (1985) · Radiation Research · doi:10.2307/3576299 · Cited by 775
Unexpected low‐dose toxicity of the universal solvent DMSO
Galvao, J., Davis, B., Tilley, M., Normando, E., Duchen, M. R., & Cordeiro, M. F. (2014) · The FASEB Journal · doi:10.1096/fj.13-235440 · Cited by 739
Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1
Langelier, M.-F., Planck, J. L., Roy, S., & Pascal, J. M. (2012) · Science · doi:10.1126/science.1216338 · Cited by 665
Regulated necrosis: disease relevance and therapeutic opportunities
Conrad, M., Angeli, J. P. F., Vandenabeele, P., & Stockwell, B. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.6 · Cited by 630
McLaughlin, M. E., Sandberg, M. A., Berson, E. L., & Dryja, T. P. (1993) · Nature Genetics · doi:10.1038/ng0693-130 · Cited by 596
Parthanatos: mitochondrial‐linked mechanisms and therapeutic opportunities
Fatokun, A. A., Dawson, V. L., & Dawson, T. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12416 · Cited by 594
Research works printed but not linked: 1
- Wei, T. et al. Generation and functional characterization of a transgenic mouse expressing a Ca2+ biosensor in cone photoreceptors. J. Neurosci. 32, 6994–6981 (2012).
Cited by
Poly(ADP-ribose) polymerase inhibition: past, present and future
Curtin, N. J., & Szabo, C. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0076-6 · Cited by 556
Retinal Inflammation, Cell Death and Inherited Retinal Dystrophies
Olivares-González, L., Velasco, S., Campillo, I., & Rodrigo, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042096 · Cited by 128
Cellular mechanisms of hereditary photoreceptor degeneration – Focus on cGMP
Power, M., Das, S., Schütze, K., Marigo, V., Ekström, P. A. R., & Paquet‐Durand, F. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.005 · Cited by 128
Self-citationDynamic lipid turnover in photoreceptors and retinal pigment epithelium throughout life
Lewandowski, D., Sander, C. L., Tworak, A., Gao, F., Xu, Q., & Skowronska‐Krawczyk, D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101037 · Cited by 117
Sphingolipids as critical players in retinal physiology and pathology
Simón, M. V., Basu, S. K., Qaladize, B., Grambergs, R. C., Rotstein, N. P., & Mandal, N. A. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr120000972 · Cited by 99
Metadata
- Authors
- Sahaboglu, A., Barth, M., Secer, E., Amo, E. M. D., Urtti, A., Arsenijevic, Y., Zrenner, E., & Paquet-Durand, F.
- Affiliations
- University of Tübingen (DE)
- University of Eastern Finland (FI)
- University of Helsinki (FI)
- Corresponding author
- Sahaboglu, Ayse
- Venue
- Scientific Reports
- Published
- 2016-12-22
- Volume
- 6
- Issue
- 1
- Pages
- 39537-39537
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5177898
- OpenAlex
- W2561847233
- Cited by
- 53
- References
- 45
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 10 · 2020: 3 · 2019: 12 · 2018: 3 · 2017: 1
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, cc-by)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- Työväentutkimus Vuosikirja (submittedVersion)
- IRIS (submittedVersion)
- Funders
- European Commission (304963)
- Deutsche Forschungsgemeinschaft (PA1751/7‐1, HEALTH-F2-2012-304963, SA3040/1-1)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- olaparib, PARP inhibitors, retinitis pigmentosa, photoreceptor degeneration, rd1 mouse model, inherited retinal degeneration, poly(ADP-ribosyl)ation, cyclic GMP, intravitreal injection, retinal explant culture, DNA repair
- MeSH terms
- Poly(ADP-ribose) Polymerase Inhibitors, Animals, Cell Survival, Chromatin, Cyclic GMP, Immunohistochemistry, Mice, Inbred C3H, Neoplasms, Phthalazines, Piperazines, Poly(ADP-ribose) Polymerases, Protein Binding, Rabbits, Retinal Degeneration, Neuroprotective Agents, Photoreceptor Cells, Vertebrate, Quantitative Structure-Activity Relationship, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Olaparib significantly delays photoreceptor loss in a model for hereditary retinal degeneration. https://app.cochat.ai/papers/10.1038/srep39537
- The paper
- Sahaboglu, A., Barth, M., Secer, E., Amo, E. M. D., Urtti, A., Arsenijevic, Y., Zrenner, E., & Paquet-Durand, F. (2016). Olaparib significantly delays photoreceptor loss in a model for hereditary retinal degeneration. Scientific Reports. https://doi.org/10.1038/srep39537
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.